• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[The correlation between post-allo-HSCT CMV infection and the difference affinity of donor HLA-type recognition of CMV antigen peptide in children].[儿童异基因造血干细胞移植后巨细胞病毒感染与供体HLA型别对巨细胞病毒抗原肽识别的差异亲和力之间的相关性]
Zhonghua Xue Ye Xue Za Zhi. 2021 Sep 14;42(9):757-762. doi: 10.3760/cma.j.issn.0253-2727.2021.09.008.
2
Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.巨细胞病毒免疫重建发生在异基因造血细胞移植受者中,无论是否存在可检测到的巨细胞病毒感染。
Biol Blood Marrow Transplant. 2005 Nov;11(11):890-902. doi: 10.1016/j.bbmt.2005.07.008.
3
[Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后长期存活患者的巨细胞病毒感染监测]
Zhonghua Yi Xue Za Zhi. 2014 Nov 4;94(40):3145-9.
4
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关:日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
5
Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.同种异体干细胞移植后免疫重建的快速监测——不同检测方法检测巨细胞病毒特异性 T 细胞的比较。
Eur J Haematol. 2013 Dec;91(6):534-45. doi: 10.1111/ejh.12187. Epub 2013 Oct 14.
6
[Clinical Analysis of Cytomegalovirus Infection after Different Patterns of Hematopoietic Stem Cell Transplantation].[不同造血干细胞移植模式后巨细胞病毒感染的临床分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Oct;23(5):1438-44. doi: 10.7534/j.issn.1009-2137.2015.05.041.
7
Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children's patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study.异基因造血干细胞移植后儿童患者巨细胞病毒感染的特点及巨细胞病毒特异性 T 细胞治疗的评价:一项回顾性单中心研究。
Front Cell Infect Microbiol. 2022 Oct 20;12:1027341. doi: 10.3389/fcimb.2022.1027341. eCollection 2022.
8
[Surveillance of cytomegalovirus for antiviral efficacy and risk factors in allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植中巨细胞病毒的抗病毒疗效及危险因素监测]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):749-54.
9
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation.某些 HLA 等位基因与异基因造血干细胞移植后巨细胞病毒再激活的风险之间的关系。
Transpl Infect Dis. 2022 Aug;24(4):e13879. doi: 10.1111/tid.13879. Epub 2022 Jul 13.
10
Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.巨细胞病毒再激活对异基因造血干细胞移植后成人再生障碍性贫血患者生存的负面影响:来自日本血液细胞移植学会移植相关并发症和成人再生障碍性贫血工作组的报告。
Transplant Cell Ther. 2021 Jan;27(1):82.e1-82.e8. doi: 10.1016/j.bbmt.2020.10.001. Epub 2020 Oct 9.

本文引用的文献

1
CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients.CMV 特异性细胞介导免疫可预测肺移植受者在预防停药后高水平的 CMV 复制。
J Infect Dis. 2021 Aug 2;224(3):526-531. doi: 10.1093/infdis/jiaa727.
2
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后 CMV 再激活的治疗策略
Blood. 2020 May 7;135(19):1619-1629. doi: 10.1182/blood.2019000956.
3
Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies.青少年和年轻成人原发性免疫缺陷患者的异基因造血干细胞移植
Front Pediatr. 2019 Oct 24;7:437. doi: 10.3389/fped.2019.00437. eCollection 2019.
4
Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis.巨细胞病毒 (CMV) 感染与异基因造血干细胞移植 (Allo-HSCT) 患者的死亡率风险:系统评价、荟萃分析和荟萃回归分析。
Am J Transplant. 2019 Sep;19(9):2479-2494. doi: 10.1111/ajt.15515. Epub 2019 Jul 24.
5
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy.造血干细胞移植后巨细胞病毒感染:现状与未来免疫治疗。
Int J Mol Sci. 2019 May 30;20(11):2666. doi: 10.3390/ijms20112666.
6
CMV specific T cell immunity predicts early viremia after liver transplantation.巨细胞病毒特异性T细胞免疫可预测肝移植后的早期病毒血症。
Transpl Immunol. 2018 Dec;51:62-65. doi: 10.1016/j.trim.2018.09.004. Epub 2018 Sep 20.
7
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion.人巨细胞病毒被膜蛋白pp65(pUL83):先天免疫逃避中的关键因子。
New Microbiol. 2018 Apr;41(2):87-94. Epub 2018 Jan 31.
8
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.一种优化的干扰素-γ酶联免疫斑点试验,用于细胞介导免疫中巨细胞病毒蛋白反应性效应细胞的灵敏且标准化监测。
BMC Immunol. 2017 Mar 7;18(1):14. doi: 10.1186/s12865-017-0195-y.
9
Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.巨细胞病毒pp65和IE1抗原刺激的特异性CD4+和CD8+T细胞的异质性
J Immunother. 2016 Nov/Dec;39(9):329-342. doi: 10.1097/CJI.0000000000000140.
10
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.2014年欧洲造血干细胞移植:每年超过4万例移植手术。
Bone Marrow Transplant. 2016 Jun;51(6):786-92. doi: 10.1038/bmt.2016.20. Epub 2016 Feb 22.

[儿童异基因造血干细胞移植后巨细胞病毒感染与供体HLA型别对巨细胞病毒抗原肽识别的差异亲和力之间的相关性]

[The correlation between post-allo-HSCT CMV infection and the difference affinity of donor HLA-type recognition of CMV antigen peptide in children].

作者信息

Yang L, Wang Z, Wu S, Lu W J, Xiong H

机构信息

Department of Hematology and oncology, Wuhan children's Hospital Affiliated to Tongji Medical College, Huazhong University of science and technology, Wuhan 430016, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2021 Sep 14;42(9):757-762. doi: 10.3760/cma.j.issn.0253-2727.2021.09.008.

DOI:10.3760/cma.j.issn.0253-2727.2021.09.008
PMID:34753231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8607047/
Abstract

To explore the correlation between the affinity while donor's HLA type recognizing different cytomegalovirus (CMV) antigen peptide and the occurrence of CMV infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children. To investigate the relationship between CMV reactivation, CMV infection or CMV related tissue/organ diseases and the different HLA-type recognition antigen peptide of the donors, we retrospectively analyzed the clinical data of 146 children with CMV infection for 6 months since from the time they underwent transplantation in Wuhan Children's Hospital. Among 146 patients, the HLA type of 82 (56.16%) cases had high affinity with PP65 alone, and 34 cases of CMV infection occurred after transplantation (41.46%) . None of 5 cases that had a high affinity with IE-1 alone got CMV infection. None of 2 cases with no clear high-affinity peptide had CMV infection. Three of 5 cases that had a high affinity with PP65 and PP50 had CMV infection. Thirteen of 52 cases that had a high affinity with PP65 and IE-1 had CMV infection (25.00%) . HLA with exclusive PP50 high affinity was not encountered. Donors with a high-affinity HLA locus associated with IE-1 showed a lower incidence of CMV infection after HSCT compared to those carrying only the PP65 high-affinity allele (22.81% 41.46%, =0.029) . HLA type with PP65 and IE-1 high-affinity covers approximately 99.8% of the donors. Stem cells generated from HLA donors with high affinity with the CMV antigen peptide IE-1 can reduce the risk of post-transplantation CMV-activated infection in children.

摘要

探讨儿童异基因造血干细胞移植(allo-HSCT)后供者人类白细胞抗原(HLA)类型识别不同巨细胞病毒(CMV)抗原肽的亲和力与CMV感染发生情况之间的相关性。为研究CMV再激活、CMV感染或CMV相关组织/器官疾病与供者不同HLA类型识别抗原肽之间的关系,我们回顾性分析了武汉市儿童医院146例自移植后6个月内发生CMV感染儿童的临床资料。146例患者中,82例(56.16%)的HLA类型仅与pp65具有高亲和力,移植后发生CMV感染34例(41.46%)。仅与IE-1具有高亲和力的5例患者均未发生CMV感染。2例无明确高亲和力肽的患者均未发生CMV感染。与pp65和PP50具有高亲和力的5例患者中有3例发生CMV感染。与pp65和IE-1具有高亲和力的52例患者中有13例发生CMV感染(25.00%)。未遇到仅与PP50具有高亲和力的HLA。与仅携带PP65高亲和力等位基因的供者相比,与IE-1相关的具有高亲和力HLA位点的供者在HSCT后CMV感染发生率较低(22.81%对41.46%,P=0.029)。具有pp65和IE-1高亲和力的HLA类型覆盖了约99.8%的供者。来自与CMV抗原肽IE-1具有高亲和力的HLA供者的干细胞可降低儿童移植后CMV激活感染的风险。